Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study.

Abuzzahab J, Dauber A, Højby M, Soltysik K, Kawai M, Murray PG, Phillip M, Battelino T

Open source

DOI
10.1093/ejendo/lvag027
Published
2026 Feb 4
Container
European journal of endocrinology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ejendo/lvag027,
  title = {Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study.},
  author = {Abuzzahab J and Dauber A and Højby M and Soltysik K and Kawai M and Murray PG and Phillip M and Battelino T},
  year = {2026},
  journal = {European journal of endocrinology},
  doi = {10.1093/ejendo/lvag027},
  url = {https://doi.org/10.1093/ejendo/lvag027}
}

RIS

TY  - JOUR
TI  - Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study.
AU  - Abuzzahab J
AU  - Dauber A
AU  - Højby M
AU  - Soltysik K
AU  - Kawai M
AU  - Murray PG
AU  - Phillip M
AU  - Battelino T
PY  - 2026
JO  - European journal of endocrinology
DO  - 10.1093/ejendo/lvag027
UR  - https://doi.org/10.1093/ejendo/lvag027
ER  - 

APA

J, A., A, D., M, H., K, S., M, K., PG, M., M, P., & T, B. (2026). Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study.. European journal of endocrinology. https://doi.org/10.1093/ejendo/lvag027

Source records